Hypereosinophilic syndrome

Known as: Syndromes, Hypereosinophilic, Hypereosinophilic Syndrome [Disease/Finding], Hypereosinophilic Syndromes 
A heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Because of advances in our understanding of the hypereosinophilic syndrome (HES) and the availability of novel therapeutic agents… (More)
  • figure 1
  • table I
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND The hypereosinophilic syndrome is a group of diseases characterized by persistent blood eosinophilia, defined as more… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND AND OBJECTIVES The hypereosinophilic syndrome (HES) may be associated with the fusion of the platelet derived growth… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Hypereosinophilic syndromes are a heterogeneous group of uncommon disorders characterized by the presence of marked peripheral… (More)
  • figure 1
  • table I
  • table II
  • table III
Is this relevant?
Review
2005
Review
2005
Hypereosinophilic syndrome (HES) is a rare disorder that is characterized by persistent and marked eosinophilia combined with… (More)
  • table I
  • table II
  • figure 2
  • figure 1
  • table III
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND IL-5 is a cytokine critically involved in regulating several aspects of eosinophils including their production… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
We recently described a subset of patients with a myeloproliferative variant of hypereosinophilic syndrome (MHES) characterized… (More)
  • table 1
  • figure 1
  • table 2
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Imatinib mesylate (Gleevec), a small molecule inhibitor of abl, kit, and platelet-derived growth factor receptor (PDGFR) tyrosine… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Patients with hypereosinophilic syndrome show persistent eosinophilia without recognised cause. We treated five such patients… (More)
Is this relevant?
1978
1978
Previous studies of patients with the hypereosinophilic syndrome have found very significant morbidity and a high mortality of 77… (More)
Is this relevant?